Gilead Sciences Announces Partial Clinical Hold on Acute Myeloid Leukemia Treatment Studies
Gilead Sciences announces FDA's partial clinical hold on acute myeloid leukemia treatment studies, pausing new participant enrollment.
News
Ingka Group Acquires Stake in Solar Development Projects in Italy
Ingka Group, the owner of IKEA, has acquired a stake in solar development projects in Italy that could generate 780 gigawatt-hours of renewable energy...
What Happens to Spousal Support After Death?
This article discusses spousal support after death, exploring whether alimony continues and the factors that may affect its continuation. It also prov...
Evgo Secures $13.8 Million Funding for Fast Charging Stations Deployment
Evgo and its partner Piolot Company secure $13.8 million funding to deploy 20 state-of-the-art fast charging stations in Ohio, advancing electric vehi...
Stocks in Toronto Dip as Consumer Durables, Energy, and Utilities Weigh on Indexes
Stocks in Toronto dip as consumer durables, energy, and utilities weigh on indexes. Technology and health tech sectors show gains. ProMIS Neuroscience...
Vanguard Expands into International Dividend Stocks
Vanguard has introduced the International Dividend Growth Fund, offering investors a chance to diversify their portfolios and capitalize on internatio...
Restart of Classes in Kentucky's Largest School District
Jefferson County Schools in Kentucky faced a setback due to transportation problems, resulting in class cancellations. The district implemented new bu...
U.S. Treasury Market Faces Continued Selloff
Barclays researchers warn of continued selloff in U.S. Treasury market as yields reach highest levels since 2007 and 2011.
Estee Lauder Faces Quarterly Loss
Estee Lauder faces a quarterly loss and lowers sales growth forecast for 2024, attributing it to slower travel retail sales in China.
The Puzzling Truth: A Cartoon Critique from China
Explore a perplexing cartoon from China that challenges conventional economic wisdom and sparks discussions about interest rates and global economic s...
All Rights Reserved © 2023